320 related articles for article (PubMed ID: 24314884)
61. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer.
Zhong C; Fang W; Mao T; Yao F; Chen W; Hu D
Ann Thorac Surg; 2012 Aug; 94(2):362-7. PubMed ID: 22727321
[TBL] [Abstract][Full Text] [Related]
62. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
63. Segmentectomy for selected cT1N0M0 non-small cell lung cancer: a prospective study at a single institute.
Nomori H; Mori T; Ikeda K; Yoshimoto K; Iyama K; Suzuki M
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):87-93. PubMed ID: 22502969
[TBL] [Abstract][Full Text] [Related]
64. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH
Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149
[TBL] [Abstract][Full Text] [Related]
65. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
Kim YT; Kang CH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
[TBL] [Abstract][Full Text] [Related]
66. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
67. Segmental resection spares pulmonary function in patients with stage I lung cancer.
Keenan RJ; Landreneau RJ; Maley RH; Singh D; Macherey R; Bartley S; Santucci T
Ann Thorac Surg; 2004 Jul; 78(1):228-33; discussion 228-33. PubMed ID: 15223434
[TBL] [Abstract][Full Text] [Related]
68. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
[TBL] [Abstract][Full Text] [Related]
69. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
[TBL] [Abstract][Full Text] [Related]
70. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
[TBL] [Abstract][Full Text] [Related]
71. Comparison of the oncologic outcomes of anatomic segmentectomy and lobectomy for early-stage non-small cell lung cancer.
Zhang L; Li M; Yin R; Zhang Q; Xu L
Ann Thorac Surg; 2015 Feb; 99(2):728-37. PubMed ID: 25497073
[TBL] [Abstract][Full Text] [Related]
72. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes.
Roman M; Labbouz S; Valtzoglou V; Ciesla A; Hawari M; Addae-Boateng E; Thorpe JA; Duffy JP; Majewski A
Eur J Surg Oncol; 2019 May; 45(5):845-850. PubMed ID: 30409440
[TBL] [Abstract][Full Text] [Related]
73. [Radical segmentectomy].
Okada M
Nihon Geka Gakkai Zasshi; 2014 May; 115(3):137-42. PubMed ID: 24946520
[TBL] [Abstract][Full Text] [Related]
74. Characteristics and risk factors of recurrence in clinical stage I non-small cell lung cancer patients undergoing anatomic segmentectomy.
Koike T; Nakamura A; Shimizu Y; Goto T; Sato S; Toyabe SI; Tsuchida M
Gen Thorac Cardiovasc Surg; 2020 Sep; 68(9):1011-1017. PubMed ID: 32198710
[TBL] [Abstract][Full Text] [Related]
75. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.
Landreneau RJ; Normolle DP; Christie NA; Awais O; Wizorek JJ; Abbas G; Pennathur A; Shende M; Weksler B; Luketich JD; Schuchert MJ
J Clin Oncol; 2014 Aug; 32(23):2449-55. PubMed ID: 24982447
[TBL] [Abstract][Full Text] [Related]
76. Predictors of early recurrence for node-negative t1 to t2b non-small cell lung cancer.
Kiankhooy A; Taylor MD; LaPar DJ; Isbell JM; Lau CL; Kozower BD; Jones DR
Ann Thorac Surg; 2014 Oct; 98(4):1175-83. PubMed ID: 25134863
[TBL] [Abstract][Full Text] [Related]
77. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma.
Chen A; Galloway M; Landreneau R; d'Amato T; Colonias A; Karlovits S; Quinn A; Santucci T; Kalnicki S; Brown D
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1057-63. PubMed ID: 10421539
[TBL] [Abstract][Full Text] [Related]
78. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
[TBL] [Abstract][Full Text] [Related]
79. A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer.
Port JL; Parashar B; Osakwe N; Nasar A; Lee PC; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2014 Oct; 98(4):1152-9. PubMed ID: 25085557
[TBL] [Abstract][Full Text] [Related]
80. Long-Term Prognosis After Segmentectomy for cT1 N0 M0 Non-Small Cell Lung Cancer.
Nomori H; Mori T; Shiraishi A; Fujino K; Sato Y; Ito T; Suzuki M
Ann Thorac Surg; 2019 May; 107(5):1500-1506. PubMed ID: 30579848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
